<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="35976" whole_study_id="13840" phs="000915" v="3" p="2" createDate="2019-08-20T11:12:02-05:00" completedByGPADate="2020-03-31T12:16:45-05:00" modDate="2021-10-12T15:35:46-05:00" maxParentChildStudyModDate="2021-10-12T15:35:46-05:00" handle="ProstateCancer_MetastaticCastrationResistant " num_participants="150"><StudyInfo accession="phs000915.v3.p2" parentAccession="phs000915.v3.p2"><BioProject id="PRJNA283922" entrez_id="283922" type="bp_admin_access"/><BioProject id="PRJNA283923" entrez_id="283923" type="bp_data_submission"/><StudyNameEntrez>Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>somatic_snv</StudyType><StudyType>targeted_exome</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Arul" lname="Chinnaiyan" email="arul@umich.edu"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Levi" lname="Garraway" email="levi_garraway@dfci.harvard.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant.  Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712).  The project was also supported by NIH awards: Clinical Sequencing Exploratory Research (CSER) UM1HG006508 (A.M.C.), Early Detection Research Network grant UO1 CA111275(A.M.C.), Prostate SPORE grants P50 CA186786 (A.M.C.), P50 CA092629 (H.S., C.L.S., Y.C.), and P50 CA097186 (P.S.N., B.M., E.M., L.T.), P01 CA163227 (P.S.N., S.P., R.B., H.D.), R01 CA116337 (M.A.R., H.B., F.D.), R01 CA155169 (C.L.S.), R01 CA092629, P50 CA092629 (H.S., C.L.S., Y.C.), and R01 CA155169 (C.L.S.)  DoD awards: W81XWH-09-1-0147 (PCCTC), DOD PC121341(H.B.).  Starr Cancer Consortium (N.S., M.R., C.S., Y.C., L.A.G.)  A.M.C. is an A. Alfred Taubman Scholar, and American Cancer Society Professor. H.B. is supported by Damon Runyon Cancer Research Foundation CI-67-13. C.P. is supported by a PCF Young Investigator Award and DoD PC131820.  E.M.V is supported by a NIH 1K08CA188615.  E.M.V., N.S. and F.Y.F. are supported by Prostate Cancer Foundation Young Investigator Awards. The RM and ICR team is supported by the Movember Foundation and Prostate Cancer UK, PCF, the ECMC network from Cancer Research UK and the Department of Health in the UK, and BRC grant funding.

</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="1585" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="1586" CGType="cg_class_DS" title="Disease-Specific (Prostate Cancer, MDS)" name="DS-PC-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Prostate Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2512" CGType="cg_class_HMB" title="Health/Medical/Biomedical (PUB, NPU)" name="HMB-PUB-NPU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2722" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>sawyersc@mskcc.org</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study><Study uid="19044" whole_study_id="13840" phs="000915" v="2" p="2" createDate="2016-04-18T11:10:13-05:00" completedByGPADate="2016-04-20T09:42:18-05:00" modDate="2020-09-01T10:26:34-05:00" maxParentChildStudyModDate="2020-09-01T10:26:34-05:00" handle="ProstateCancer_MetastaticCastrationResistant " num_participants="150"><StudyInfo accession="phs000915.v2.p2" parentAccession="phs000915.v2.p2"><BioProject id="PRJNA283922" entrez_id="283922" type="bp_admin_access"/><BioProject id="PRJNA283923" entrez_id="283923" type="bp_data_submission"/><StudyNameEntrez>Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>somatic_snv</StudyType><StudyType>targeted_exome</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Arul" lname="Chinnaiyan" email="arul@umich.edu"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Levi" lname="Garraway" email="levi_garraway@dfci.harvard.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant.  Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712).  The project was also supported by NIH awards: Clinical Sequencing Exploratory Research (CSER) UM1HG006508 (A.M.C.), Early Detection Research Network grant UO1 CA111275(A.M.C.), Prostate SPORE grants P50 CA186786 (A.M.C.), P50 CA092629 (H.S., C.L.S., Y.C.), and P50 CA097186 (P.S.N., B.M., E.M., L.T.), P01 CA163227 (P.S.N., S.P., R.B., H.D.), R01 CA116337 (M.A.R., H.B., F.D.), R01 CA155169 (C.L.S.), R01 CA092629, P50 CA092629 (H.S., C.L.S., Y.C.), and R01 CA155169 (C.L.S.)  DoD awards: W81XWH-09-1-0147 (PCCTC), DOD PC121341(H.B.).  Starr Cancer Consortium (N.S., M.R., C.S., Y.C., L.A.G.)  A.M.C. is an A. Alfred Taubman Scholar, and American Cancer Society Professor. H.B. is supported by Damon Runyon Cancer Research Foundation CI-67-13. C.P. is supported by a PCF Young Investigator Award and DoD PC131820.  E.M.V is supported by a NIH 1K08CA188615.  E.M.V., N.S. and F.Y.F. are supported by Prostate Cancer Foundation Young Investigator Awards. The RM and ICR team is supported by the Movember Foundation and Prostate Cancer UK, PCF, the ECMC network from Cancer Research UK and the Department of Health in the UK, and BRC grant funding.

</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="1585" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="1586" CGType="cg_class_DS" title="Disease-Specific (Prostate Cancer, MDS)" name="DS-PC-MDS" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Prostate Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="2512" CGType="cg_class_HMB" title="Health/Medical/Biomedical (PUB, NPU)" name="HMB-PUB-NPU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup><ConsentGroup uid="2722" CGType="cg_class_GRU" title="General Research Use" name="GRU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data is limited only by the terms of the model Data Use Certification.

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>sawyersc@mskcc.org</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="13840" whole_study_id="13840" phs="000915" v="1" p="1" createDate="2015-05-12T15:16:35-05:00" completedByGPADate="2015-05-12T16:35:22-05:00" modDate="2020-09-01T09:46:21-05:00" maxParentChildStudyModDate="2020-09-01T09:46:21-05:00" handle="ProstateCancer_MetastaticCastrationResistant " num_participants="150"><StudyInfo accession="phs000915.v1.p1" parentAccession="phs000915.v1.p1"><BioProject id="PRJNA283922" entrez_id="283922" type="bp_admin_access"/><BioProject id="PRJNA283923" entrez_id="283923" type="bp_data_submission"/><StudyNameEntrez>Integrative Clinical Sequencing Analysis of Metastatic Castration Resistant Prostate Cancer Reveals a High Frequency of Clinical Actionability</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="somatic_snv"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/><StudyType22 name="tumor_normal"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>germline</StudyType><StudyType>tumor_normal</StudyType><StudyType>somatic_snv</StudyType><StudyType>targeted_exome</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="true" primary="true"/></ICs><Persons><Person aid="8" auth="virtual" fname="Arul" lname="Chinnaiyan" email="arul@umich.edu"><Role>PI</Role><Organization/></Person><Person aid="8" auth="virtual" fname="Levi" lname="Garraway" email="levi_garraway@dfci.harvard.edu"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011552437" aid="1" auth="cit" login="jawang" fname="Zhen" mname="Yuan" lname="Wang" email="zhen.wang@nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001203526" aid="1" auth="cit" login="cagaananef" fname="Emilie" mname="Charlisse F" lname="Caga-Anan" email="charlisse.caga-anan@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was supported by a Stand Up To Cancer-Prostate Cancer Foundation Prostate Dream Team Translational Cancer Research Grant.  Stand Up To Cancer is a program of the Entertainment Industry Foundation administered by the American Association for Cancer Research (SU2C-AACR-DT0712).  The project was also supported by NIH awards: Clinical Sequencing Exploratory Research (CSER) UM1HG006508 (A.M.C.), Early Detection Research Network grant UO1 CA111275(A.M.C.), Prostate SPORE grants P50 CA186786 (A.M.C.), P50 CA092629 (H.S., C.L.S., Y.C.), and P50 CA097186 (P.S.N., B.M., E.M., L.T.), P01 CA163227 (P.S.N., S.P., R.B., H.D.), R01 CA116337 (M.A.R., H.B., F.D.), R01 CA155169 (C.L.S.), R01 CA092629, P50 CA092629 (H.S., C.L.S., Y.C.), and R01 CA155169 (C.L.S.)  DoD awards: W81XWH-09-1-0147 (PCCTC), DOD PC121341(H.B.).  Starr Cancer Consortium (N.S., M.R., C.S., Y.C., L.A.G.)  A.M.C. is an A. Alfred Taubman Scholar, and American Cancer Society Professor. H.B. is supported by Damon Runyon Cancer Research Foundation CI-67-13. C.P. is supported by a PCF Young Investigator Award and DoD PC131820.  E.M.V is supported by a NIH 1K08CA188615.  E.M.V., N.S. and F.Y.F. are supported by Prostate Cancer Foundation Young Investigator Awards. The RM and ICR team is supported by the Movember Foundation and Prostate Cancer UK, PCF, the ECMC network from Cancer Research UK and the Department of Health in the UK, and BRC grant funding.

</acknowledgement_statement><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=13842&amp;file=get&amp;page=file" filename="eNCI_0235_DUC_2015.05.12.rtf" md5="e3d67bb3c7140a491c81a4d91b597943" size="234732" modDate="2015-05-12T15:30:39-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=14180&amp;file=get&amp;page=file" filename="eNCI_0235_DUC_2015.05.12.rtf.pdf" md5="8e194315f2c91632b73b7fa42cd107d7" size="185263" modDate="2015-06-18T14:25:23-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="1585" CGType="cg_class_DS" title="Disease-Specific (Cancer, MDS)" name="DS-CA-MDS" dac_uid="62" dac_name="eNCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><ConsentGroup uid="1586" CGType="cg_class_DS" title="Disease-Specific (Prostate Cancer, MDS)" name="DS-PC-MDS" dac_uid="62" dac_name="eNCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Prostate Cancer.
Use of the data includes methods development research (e.g., development of software or algorithms).

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>sawyersc@mskcc.org</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>